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Smoking during pregnancy is a key contributor to poor infant health. Our study presents a dynamic 
relationship between the timing of prenatal smoking cessation or reduction and infant birth weight. 
Using a large representative dataset of a birth cohort in the United Kingdom, we apply regression 
analysis to examine the influences of cessation in smoking or reduction in smoking intensity at different 
months or trimesters on infant birth weight. For robustness checks, we use a rich set of additional 
covariates, a series of variable selection procedures, alternative birth outcome measures, and stratified 
samples. We find robust evidence that mothers who quit smoking by the third month of pregnancy or 
the end of the first trimester have infants of the same weight as those infants of nonsmokers. However, 
we find smoking cessation in the fourth month or any time beyond is associated with substantially lower 
infant birth weights. Two-thirds of the total adverse smoking impact on infant birth weight occurs in the 
second trimester. Our study also shows mothers who smoke throughout pregnancy but cut smoking 
intensity by the third month in pregnancy deliver infants of the same weight as those infants born to 
persistent light smokers. Our research suggests the efficacy of prenatal smoking cessation services can 
be significantly improved, if health professionals can encourage more pregnant women to quit smoking 
or reduce smoking intensity timely by the end of the first trimester. 
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Prenatal smoking is a key contributor to poor infant health in developed countries. Since the seminal 
work of Simpson [1], a number of studies have consistently found prenatal smoking is associated with a 
reduction of birth weight of offspring by 150–250 grams (g) [2]. In addition, previous research has also 
linked smoking during pregnancy to many other adverse birth outcomes such as low birth weight, 
preterm birth, intrauterine growth retardation, placental abruption, and sudden infant death syndrome 
[3– 5]. Despite voluminous evidence on the smoking’s harmful impacts on infant health, the prevalence 
of maternal smoking is still quite high in industrial countries [6]. Tong et al. [7] finds about 22–24 % of 
women in the United States smoked just before or during pregnancy in 2000–2005. In the same period, 
33–35 % of women across the United Kingdom (UK) reported smoking prior to or during pregnancy, and 
about 60 % of these smokers had smoked throughout pregnancy [8]. 
Given the large percentage of prenatal smokers and the detrimental impacts of maternal smoking on 
infants, policies to encourage smoking cessation are increasingly being pursued. The UK government has 
set reduction in prenatal smoking as a top priority for National Health Service (NHS) [9]. The NHS has 
provided comprehensive cessation services to female smokers who are either pregnant or are planning 
a pregnancy, because both smoking cessation and reduction can substantially mitigate the smoking 
associated deficits in birth outcomes [10, 11]. These services   provided   by   the   NHS   include   a   
variety   of recommended strategies, such as individual counseling, group behavior therapy, 
pharmacotherapies, and telephone quit-lines [12]. Similar strategies are used in other industrial 
countries such as the United States [13, 14]. 
The guidance for the wide range of cessation treatments, however, has been vague in the timing issue of 
prenatal smoking cessation or reduction. No guideline for health professional has stated by what month 
during pregnancy prenatal smokers should quit to ensure that mothers deliver infants of the same 
weight as those infants of nonsmokers. Similarly, no guideline has specified by what time during 
pregnancy persistent smokers should reduce smoking intensity to significantly mitigate the adverse 
impact of smoking on infant health. The importance of the timing issue cannot be understated. A well 
specified deadline in pregnancy for women to cut smoking can significantly improve the efficacy of any 
prenatal smoking cessation intervention [15, 16]. 
To date, the literature has provided conflicting results on how the timing of prenatal smoking cessation 
affects birth outcomes especially birth weight. Some studies demonstrate infants of women who quit 
smoking by the seventh month during pregnancy weigh the same as those infants of nonsmokers [17–
19]. However, Macarthur and Knox [20] show that smoking cessation by the end of the second trimester 
only mitigates the harmful impact of smoking on newborn birth weight. Several other studies suggest 
women must quit before the second trimester to make fetal exposure to smoking have a negligible 
effect on infant health [21–24]. Similarly, limited evidence has been reported on the timing of prenatal 
smoking reduction [17, 19]. In summary, no consensus has been reached on whether the beginning of 
the second or third trimester is the threshold for the initiation of acute fetal response to smoking. 
One limitation of all the above studies is that the datasets used only identify maternal smoking status a 
few times during or prior to pregnancy. Given the lack of data, these studies are unable to adequately 
evaluate the effects of stopping or reducing cigarette use by different stages especially different months 
of a pregnancy. In addition, most of the data in the previous studies are highly selective (from a few 
hospitals or regions) and lack of important parental socioeconomic control variables. Our research 
advances the literature by presenting a full dynamics of the timing of fetal exposure to smoking in 
relation to infant birth weight. We use a unique UK birth cohort dataset which contains information on 
maternal smoking status month by month during pregnancy. The dataset is also a representative sample 
of all the UK pregnant women, which provides a rich set of infant, parental, and family level covariates. 
All these advantages of our dataset provide a unique opportunity to investigate the timing issue on 
prenatal smoking cessation and reduction. 
  
Methods 
Study Design and Population 
Our study uses data from the first wave of the UK Millennium Cohort Study (MCS). MCS is an on-going 
population based survey which tracks a large child cohort from birth throughout childhood into 
adolescence. Our research uses a random sample of infants (aged 9 months on average) from the first 
wave of MCS drawn from all the live births in the UK during 2000 and 2001. This cohort was 
disproportionately stratified to ensure adequate representation of all the four UK countries. As a 
secondary analysis of anonymized data, our study is conducted in accord with prevailing ethical 
principles. 
We construct two samples in this research, one on prenatal smoking cessation and the other on smoking 
reduction. In constructing the smoking cessation sample, we start with 13,495 women who answered all 
the survey questions, reported their histories of cigarette use, and provided complete information on 
their demographic characteristics. Then we exclude the following observations: missing data on infant 
birth weight (n = 30); women with multiple births (n = 240); women with preconception health risk 
factors (cancer, diabetes, hypertension, and asthma) known to affect prenatal smoking cessation by 
impairing fetal growth [19, 22] (n = 642); women using other tobacco products such as cigar or roll-ups 
(n = 361); missing data of family income (n = 825), and missing information on who else was present at 
the baby’s birth (n = 266). The final sample has 11,131 mothers with singleton births. Similar exclusion 
conditions are applied to construct our second sample of smoking reduction. This sample, which has 
2,306 smokers, is limited to persistent smokers who never quit smoking but may change the number of 
daily cigarettes smoked during pregnancy. 
 
Measures 
Women who participated in the first wave of MCS were asked a series of questions on tobacco use 
including whether the respondents had ever smoked, the type of tobacco products they had used, the 
number of cigarettes they had smoked per day before pregnancy, the month of the pregnancy they had 
changed the daily cigarette consumption, and the daily number of cigarettes smoked after this change. 
In the smoking cessation sample, we classify women as: nonsmokers (the reference group), 
preconception quitters who stopped smoking before pregnancy, month ‘‘j’’ quitters who gave up 
smoking in pregnancy month ‘‘j’’ (j = 1, 2,…, 7),  and  beyond-month-seven smokers who ceased smoking 
after the seventh month or smoked throughout pregnancy. Only a few mothers in the sample quit 
smoking after the seventh month, giving little statistical power to estimate the impact of cessation in 
either the eighth or ninth month. Therefore, we group mothers who quit smoking in the eighth or ninth 
month with persistent smokers. Grouping these late quitters with persistent smokers is innocuous to 
explore the deadline month of smoking cessation, since all the previous studies indicate prenatal 
smoking should have substantially impaired infant health before the eighth month [17–23]. 
In the smoking reduction sample, we classify persistent smokers into seven categories. The first is our 
reference group of persistent light smokers who smoked no more than 10 cigarettes daily throughout 
pregnancy [17]. The second through sixth categories are women who reduced the number of daily 
cigarettes smoked to less than 10 in month ‘‘k’’ (k = 1, 2,…,5). Our last category consists of mothers who 
smoked persistently throughout pregnancy and only reduced daily smoking intensity to less than 10 
after the fifth month and mothers who never reduced smoking to less 10 cigarettes per day in 
pregnancy. Again, due to the small number of the women who reduced smoking beyond the fifth 
month, we group them with persistent heavy smokers. Lastly, in our following analysis, prenatal 
smokers are also re-categorized by the trimester of smoking cessation or reduction to provide additional 
insights. 
We choose infant birth weight as the outcome of primary interest. Birth weight is the most frequently 
used measure on infant health. Past studies have shown increasing infant birth weight causally improves 
childhood health, cognitive development, and adulthood educational attainment and earnings [25–28]. 
Our research also examines two additional infant health measures strongly associated with prenatal 
smoking: low birth weight (birth weight < 2,500 g, henceforth LBW) and preterm birth (gestation < 37 
weeks). Such two poor birth outcomes not only impose large economic costs for the individuals and the 
society, but also have lasting impacts on a variety of lifetime outcomes [5, 24, 28]. Because the original 
survey questionnaire does not code gestational age, we have to use estimated gestational age derived 
by the MCS team in 2004 which makes it difficult to precisely identify all the preterm births, admittedly 
a limitation. 
We include many potential determinants on infant health other than smoking in the baseline regression: 
birth characteristics (infant male, parity, birth year/quarter), parental demographics (age, race, 
ethnicity, and education), maternal socioeconomic status (marital status, prenatal care initiation in the 
first trimester, family income measured by OECD equivalised monthly income, and father present  at the 
baby’s  birth),  and maternal  health status and behavior (preconception height and weight, any alcohol 
use during pregnancy). We use the indicator on father’s presence at a baby’s birth to capture paternal 
involvement in pregnancy such as a father’s willingness to devote resources to fetal development. For 
instance, an expectant father can help improving infant health by making his spouse/partner quit 
smoking timely during pregnancy. For robustness checks, we further control for the following mother 
level variables: having a job during pregnancy, receiving any benefits, being satisfied about the current 
home, religion affiliations, frequent alcohol use during pregnancy (alcohol use at least three times a 
week), and indicators of racist and religion-based insults in mothers’ living areas. 
In Table 1, we present the summary statistics of the three dependent variables and the key covariates 
used in the baseline regression. The descriptive statistics of the additional controls in sensitivity analysis 
are not reported to save space. In Column (1) we focus on the full sample of smoking cessation. In 
Columns (2) to (5), we stratify this whole sample into four subsamples by the trimester of smoking 
cessation. The first three rows indicate the birth outcomes of the mothers who stopped smoking in the 
first trimester were similar to the nonsmokers. Mothers who smoked beyond the first trimester, 
however, had much worse birth outcomes than the nonsmokers and trimester 1 quitters. 
The means in other rows show the control variables also vary by smoker type. Compared with 
nonsmokers, preconception quitters, and trimester 1 quitters, mothers who smoked through the second 
trimesters had lower educational attainment and lower family income, were less likely to be married 
and initiate prenatal care in the first trimester, and were more likely to use alcohol during pregnancy. 
Although almost all the sampled mothers are UK citizens or foreigners living lawfully in UK and thereby 
entitled to free prenatal care under the UK universal healthcare system, we find marked variation in the 
timing of prenatal care initiation across nonsmokers and different types of smokers. In general, mothers 
of low socioeconomic status tended to delay smoking cessation in pregnancy. Since birth outcomes are 
also affected by socioeconomic status variables, controlling for these covariates (education, income, and 
marital status) is important to disentangle the independent impact of smoking cessation on infant 
health [17, 22–24]. Finally, in Column (6) we report the summary statistics of the smoking reduction 
sample. 
In Fig. 1, we show the average birth weights of the infants of nonsmokers and smokers who differ in the 
month of smoking cessation. We find birth outcomes of nonsmokers and preconception quitters were 
similar and so we use them as the base for comparison. We also find infants born to mothers who 
ceased smoking in the first three pregnancy months weighed almost the same as infants of nonsmokers 
or preconception quitters. However, infants delivered by mothers who quit smoking in the fourth month 
weighed 120–160 g less than infants born to mothers who quit smoking earlier or never smoked. In 
addition, smoking beyond the fourth month was further associated with a decrease in infant birth 
weight by about 50–100 g. 
In Fig. 2, we report the average infant birth weights by grouping mothers by the trimester of smoking 
cessation. We find, when mothers gave up smoking in the first trimester, their infants weighed nearly 
the same as infants of nonsmokers or preconception quitters. In contrast, mothers who smoked through 
the second trimester had infants with much lower birth weights. This preliminary comparison of means 
in the two figures suggests that prenatal smokers have to quit by the third month to avoid the initiation 
of acute fetal response to smoking. We find similar results in the graphical analysis on smoking 
reduction among persistent smokers (not shown). 
 
Statistical Analysis 
We use multiple linear regressions to study the relationship between the timing of prenatal smoking 
cessation or reduction and infant birth weight. Our benchmark specification controls for the basic 
confounding factors. We then include a number of additional covariates for robustness checks. As 
another sensitivity analysis, we implement four variable selection procedures rarely used in this 







Our first procedure is forward selection. We start with adding the most significant explanatory variable 
into an initial model with no input, then continue adding variables until none of the remaining variables 
are significant at 10 % (p < 0.1). In contrast, a backward selection keeps eliminating insignificant 
explanatory variables until the p-values of the remaining variables are all < 0.1. In a forward stepwise 
selection, explanatory variables once entered may be dropped, if they are not significant at 10 % as 
other variables are included. Finally, a backward stepwise selection starts with a backward selection 
procedure, and then adds back variables dropped earlier if they later on appear to be significant. To the 
best of our knowledge, only two studies in this large literature [19, 29] have used forward and backward 
selection procedures and none has applied the two stepwise methods. 
 
 
Each  selection  procedure  screens  all  the  explanatory variables  including  smoking  measures,  which  
gives  a subset  of  those  variables  with  significant  explanatory power on infant birth weight. If a 
certain month is the threshold when smoking begins to adversely affect infant birth weight, then the 
indicator of smoking cessation in this month should survive every variable selection procedure. The 







In Table 2, we address the impact of prenatal smoking cessation by month on infant birth weight. In 
Column (1), we show the estimated impacts of smoking cessation before or in the first 3 months of 
pregnancy are all small and insignificant. However, stopping cigarette use as late as the fourth month 
(the threshold month) significantly reduces infant birth weight by 140 g (p = 0.03). We find smoking 
cessation between the fifth and seventh month during pregnancy leads to larger reductions in birth 
weight which range from 175 to 217 g. If mothers smoke beyond the seventh month, then their babies  
will  weigh  about 249 g less than infants born to nonsmokers (p < 0.01). In Column (1), we also find 
newborn babies are of higher weight if their mothers are more educated, younger, married, living in 
North Ireland or Scotland, or if their fathers are younger than 40 and present at babies’ births. 
We find the results in Column (2) are very similar to Column (1), when additional confounding factors 
are controlled for. We then implement the four variable selection approaches, all of which provide 
identical results. To save room, we only report the outcomes of a forward selection and backward 
selection procedure in Columns (3) and (4). In all the four selection procedures, we find the four 
indicators of smoking cessation before the fourth month are dropped, suggesting mothers who quit 
before the fourth month have infants of the same birth weight as nonsmokers. In contrast, we find 
smoking cessation in the fourth month is always a significant predictor of having babies of lower weights 
(p = 0.02). The indicators of smoking beyond the fourth month are also selected into the final models. 
Overall, our results suggests prenatal smokers must quit by the end of the first trimester (before the 
fourth month threshold) to nullify the adverse smoking impact on newborn babies. 
 
In Table 3, we study the relationship between smoking cessation by trimester and infant birth weight. In 
Column (1), we find when mothers quit smoking prior to pregnancy or in the first trimester, fetal 
exposure to smoking will have a negligible effect on birth weight. Smoking cessation in the second 
trimester, however, is still significantly associated with much lower birth weights by 160 g (p < 0.01). In 
addition, we find smoking beyond the second trimester reduces birth weight by 248 g (p < 0.01). 
Comparing the two estimates, we find two-thirds of the total deleterious smoking impact on infant birth 
weight occurs in the second trimester. Our results are robust in the presence of additional covariates in 
Column (2) and with two variable selection procedures in Columns (3) and (4). The estimates of the two 
stepwise selection approaches (not reported) are the same as Columns (3) and (4). Although several 
past studies find that mothers can postpone smoking cessation until the end of the second trimester to 
deliver infants of the same weight as infants of nonsmokers [17–19], our results in Tables 2 and 3 
present robust counter evidence. In Table 4, we examine how the timing of smoking reduction affects 
birth weights of infants born to persistent smokers. In Column (1), we show if mothers substantially 
reduce  smoking  intensity  in  the  first  3 months  during pregnancy,  their  infants  will  be  
indistinguishable  from babies  of  the  persistent  light  smokers  in  term  of  birth 
 
 
weight. However, we find switching from heavy to light smoking as late as the fourth month still leads to 
lower infant birth weights by 58 g (p = 0.03). Heavy smoking beyond the fourth month further decreases 
infant birth weight by 19–31 g. When we add additional covariates in Column (2), the results are very 
similar. In Columns (3) and (4), we present estimates on smoking reduction by trimester. In both 
columns we find heavy smokers have to reduce smoking intensity before the second trimester, in order 
to deliver infants who weigh the same as infants born to the persistent light smokers. Our results are 
robust to the four variable selection approaches (not shown for brevity). To summarize, we find even if 
some heavy smokers cannot completely quit smoking during pregnancy, they can substantially mitigate 
the detrimental smoking impact on infant birth weight through reducing smoking intensity by the end of 
the first trimester. 
In Table 5, we report the estimated impacts of the timing of smoking cessation on LBW and preterm 
birth. Because of the low prevalence of the two birth outcomes and the small number of mothers who 
stopped smoking after the fifth month, we group those late quitters with persistent smokers to increase 
statistical power. In Columns (1) and (3), we show smoking cessation by the third month during 
pregnancy does not significantly increase the risks of LBW and preterm birth. However, smoking 
cessation in the fourth month still leads to significantly higher risks of LBW (p = 0.07) and preterm birth 
(p = 0.09), consistent with the results on birth weight in Table 2. In Columns (2) and (4), our results 
indicate while smoking cessation  by  the  first  trimester  nullifies the  impacts of smoking on the two 
poor birth outcomes, smoking cessation beyond the first trimester significantly increases the incidences   
of   LBW   (p = 0.01)   and   preterm   birth (p = 0.08). We also examine the relationship between smoking 
reduction and the two birth outcomes. Since the small sample of smoking reduction provides low 
statistical power even when smokers are grouped by trimester, the regression estimates are nearly all 
insignificant. Nevertheless, when we test for the differences of means, these tests show mothers who 
smoke heavily through the fourth month are significantly more likely to have LBW or preterm birth 
babies than those mothers who reduce smoking intensity by the third month (p < 0.1). The results are 
available upon request. 
In Table 6, we conduct several subsample analyses, with all the control variables added into regressions. 
In Column (1), we limit the sample to nonsmokers, preconception quitters, and trimester 1 quitters. Our 
results show the effects of smoking cessation before or in the first 3 months of pregnancy on birth 
weight are small and insignificant. In Column (2), we restrict the sample to nonsmokers, preconception 
quitters, trimester 2/3 quitters and persistent smokers. We find smoking through the fourth month (the 
beginning of the second trimester) reduces birth weight by 141–244 g (p < 0.1). Our results are very 
close to Table 2. In Columns (3) and (4), we focus on two stratified subsamples of England and other UK 
countries, respectively. We find the results in both columns are again consistent with Table 2. Finally, we 
find the benchmark estimates in Column (2) of Tables 2 and 4 are virtually unchanged, when we further 
control for an indicator of urban areas and another indicator on high barriers to hospital care, with the 






Our study uses a large UK birth cohort dataset to shed new light on the relationship between the timing 
of prenatal smoking cessation or reduction and infant birth weight. We find mothers who quit smoking 
by the third month during pregnancy (before the fourth month threshold) have infants of the same 
weight as infants of nonsmokers. We find, however, smoking cessation in the fourth month or any time 
beyond is associated with substantially lower infant birth weights. Two-thirds of the total adverse 
smoking impact on infant birth weight occurs in the second trimester. Our study also shows mothers 
who smoke throughout pregnancy but cut smoking intensity by the third month in pregnancy deliver 
infants of the same weight as infants born to persistent light smokers. Our findings are robust as we use 
a rich set of additional covariates, a series of variable selection procedures, alternative birth outcome 
measures, and stratified samples. 
One possible limitation of our study is recall error in smoking cessation or reduction. The number of 
such errors may be small, since mothers were interviewed a few months after delivering their babies. 
Due to data limitations, we are unable to address how the timing of smoking cessation or reduction 
affects other interesting birth outcomes such as crown-heel length, head circumference, and the 
development of infant brain system. Lastly, this analysis is limited to one birth cohort. 
Overall, our findings highlight the importance to incorporate the timing issue into prenatal smoking 
cessation interventions. Several evaluations show the NHS stop smoking intensive treatments only lead 
to low quit rates among prenatal smokers [30, 31]. In addition, some recent reviews of randomized 
clinical cessation trials report the current prenatal smoking programs have had limited success, not only 
in the UK but also in other developed countries such as the United States [32, 33]. Our research, 
however, shows at any given rate of smoking cessation or reduction, the efficiency of prenatal smoking 
cessation programs still can be significantly improved, particularly, if health professionals can curb 
smoking early in pregnancy especially by the end of the first trimester. At the aggregate level, promotion 
of timely prenatal smoking cessation and reduction allows policy makers and medical practitioners to 
significantly reduce the huge costs of poor birth outcomes due to prenatal smoking [34, 35]. Future 
research can explore the enhanced benefit-ratios of the smoking cessation programs which expedite 
smoking cessation or reduction in pregnancy, using estimates of our study, savings on healthcare 
expenses due to improved birth outcomes, and cost estimates of those cessation programs. 
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